The LDN Shop
Visit our e-commerce website for Conferences, Webinars, Medical Membership, eBooks etc
Cameon LDN and Multiple Sclerosis (MS) (low dose naltrexone) from LDN Research Trust on Vimeo.
Cameon from the USA shares her story of going from 7 years in a wheelchair to walking, after taking Low Dose Naltrexone for 10 months.
Her speech is slow but improved as one of the symptoms he suffered from Multiple Sclerosis (MS).
Low-Dose Naltrexone: An Inexpensive Medicine for Many Ills?
Medscape Medical News
11 Mar 2020
https://www.medscape.com/viewarticle/926611?src=WNL_trdalrt_201027_MSCPEDIT&uac=267476HJ&impID=2640101&f
Ulrich Lanius, PhD and Galyn Forster, MS, LPC - Opioid Antagonists and Traumatic Brain Injury (2017 Conference) (LDN, low dose naltrexone)
They begin their presentation by discussing Naltrexone and seizure activity, as demonstrated through clinical trials. They found that later dosage adjustments were helpful in reducing the cognitive effects.
Jill Brook M.A. - Dietary Strategies to Fight Autoimmunity (2017 Conference) (LDN, low dose naltrexone)
Jill Brook, MA shares her presentation on Nutrition at the LDN 2017 Conference.
Jarred Younger, PhD - Calming microglia: a future method for treating multiple sclerosis (2016 Conference) (LDN, low dose naltrexone)
Dana Flavin, MD - Reversing Cancer with Biochemistry (2018 Conference) (LDN, low dose naltrexone)
Dr Dana Flavin shares her presentation on Reversing Cancer at the LDN 2018 Conference.
Mark Shukhman, MD - Sexual Function (2016 Conference) (LDN, low dose naltrexone)